Related Experiment Video
Updated: Aug 11, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing
Abstract:
The cost-effectiveness of clinical pharmacist intervention in reducing the use of tobramycin and in the pharmacokinetic monitoring of aminoglycoside therapy to prevent serious nephrotoxicity were evaluated. Prescribing practices for tobramycin were compared between two similar medical teams, one with clinical pharmacist services, the other without. A statistically significant difference was observed between the number of patients who received tobramycin in the two teams, and a cost saving of $5,072.85 was achieved in 3 months. The potential for hospitalwide cost savings is substantial if gentamicin can be substituted for tobramycin in selected circumstances and followed with appropriate monitoring.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Therapeutic Drug Monitoring: Affecting Factors
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Clinical Significance of Antibiotic Resistance

